dc.contributor.author | Yamaner, Sumer | |
dc.contributor.author | bugra, Dursun | |
dc.contributor.author | canbay, Emel | |
dc.contributor.author | Zeybek, Umit | |
dc.contributor.author | Ergen, Arzu | |
dc.contributor.author | Bulut, Turker | |
dc.date.accessioned | 2021-03-04T18:58:44Z | |
dc.date.available | 2021-03-04T18:58:44Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Ergen A., canbay E., bugra D., Zeybek U., Yamaner S., Bulut T., "Plasma Kisspeptin-54 levels in gastric cancer patients.", International journal of surgery (London, England), cilt.10, ss.551-4, 2012 | |
dc.identifier.issn | 1743-9191 | |
dc.identifier.other | av_8d79688c-1616-4e04-873b-6163ce1419ff | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/95640 | |
dc.identifier.uri | https://doi.org/10.1016/j.ijsu.2012.08.014 | |
dc.description.abstract | Background: Kisspeptin (Kisspeptin-54; KP-54) is a 54-amino acid peptide was originally known as metastin that was implicated in suppression of tumor metastasis and circulating kisspeptin has been proposed as a tumor marker for numerous cancers in humans. However, the plasma level of KP-54 in gastric cancer (GC) remains undetermined. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | CERRAHİ | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.title | Plasma Kisspeptin-54 levels in gastric cancer patients. | |
dc.type | Makale | |
dc.relation.journal | International journal of surgery (London, England) | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 10 | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | 551 | |
dc.identifier.endpage | 4 | |
dc.contributor.firstauthorID | 75666 | |